S, C., C, S., N, A., V, M., C, M., R, U., . . . C, H. (2024). CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network. American journal of hematology, 99(7), 1240. https://doi.org/10.1002/ajh.27316
Chicago Style (17th ed.) CitationS, Choquet, et al. "CAR T-cell Therapy Induces a High Rate of Prolonged Remission in Relapsed Primary CNS Lymphoma: Real-life Results of the LOC Network." American Journal of Hematology 99, no. 7 (2024): 1240. https://doi.org/10.1002/ajh.27316.
MLA (9th ed.) CitationS, Choquet, et al. "CAR T-cell Therapy Induces a High Rate of Prolonged Remission in Relapsed Primary CNS Lymphoma: Real-life Results of the LOC Network." American Journal of Hematology, vol. 99, no. 7, 2024, p. 1240, https://doi.org/10.1002/ajh.27316.